Cargando…

Interleukin-34 and immune checkpoint inhibitors: Unified weapons against cancer

Interleukin-34 (IL-34) is a cytokine that is involved in the regulation of immune cells, including macrophages, in the tumor microenvironment (TME). Macrophages are a type of immune cell that can be found in large numbers within the TME and have been shown to have a role in the suppression of immune...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alshaebi, Fadhl, Safi, Mohammed, Algabri, Yousif A., Al-Azab, Mahmoud, Aldanakh, Abdullah, Alradhi, Mohammed, Reem, Alariqi, Zhang, Caiqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927403/ https://www.ncbi.nlm.nih.gov/pubmed/36798830 http://dx.doi.org/10.3389/fonc.2023.1099696

Ejemplares similares

IL-34 and Immune Checkpoint Inhibitors Resistant through Macrophages: Pan-Cancer Overview
por: Safi, Mohammed, et al.
Publicado: (2023)

Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: a clinicogenomic TCGA study
por: Safi, Mohammed, et al.
Publicado: (2022)

Overall Survival in Heart Disease–Related Death in Non-Small Cell Lung Cancer Patients: Nonimmunotherapy Versus Immunotherapy Era: Population-Based Study
por: Safi, Mohammed, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor (ICI) Genes and Aging in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical and Genomic Study
por: Al-Danakh, Abdullah, et al.
Publicado: (2022)

Aging of mesenchymal stem cell: machinery, markers, and strategies of fighting
por: Al-Azab, Mahmoud, et al.
Publicado: (2022)

A novel nomogram and prognostic factor for metastatic renal cell carcinoma survival in the era of immune checkpoint inhibitors (ICIs)
por: Alradhi, Mohammed, et al.
Publicado: (2023)

Surgery Treatment Improved the Overall Survival Rate in Locoregional Myxoid Leiomyosarcoma than Other Myxosarcomas in the United States
por: Almoiliqy, Marwan, et al.
Publicado: (2021)

Vγ9Vδ2 T Cells as Strategic Weapons to Improve the Potency of Immune Checkpoint Blockade and Immune Interventions in Human Myeloma
por: Castella, Barbara, et al.
Publicado: (2018)

Laparoscopic retroperitoneal resection of the duodenal gastrointestinal stromal tumors in neurofibromatosis type 1; Case Report and literature review
por: Abdullah, Al-Danakh, et al.
Publicado: (2022)

Mir-34: A New Weapon Against Cancer?
por: Misso, Gabriella, et al.
Publicado: (2014)

A case report of rare granular cell tumor of the urinary bladder
por: Wahid, Saman Anwar, et al.
Publicado: (2022)

Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade
por: Hama, Naoki, et al.
Publicado: (2020)

Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade
por: Hama, Naoki, et al.
Publicado: (2022)

Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche
por: Solimando, Antonio Giovanni, et al.
Publicado: (2022)

No Overall Survival Difference in the Immunotherapy Era for Rare Subtypes of Melanoma
por: Safi, Mohammed, et al.
Publicado: (2021)

Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study
por: Alradhi, Mohammed, et al.
Publicado: (2022)

Molecular genetic and clinical characteristic analysis of primary signet ring cell carcinoma of urinary bladder identified by a novel OR2L5 mutation
por: Alradhi, Mohammed, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors: New Weapons Against Medullary Thyroid Cancer?
por: Di Molfetta, Sergio, et al.
Publicado: (2021)

Immune Checkpoint and Telomerase Crosstalk Is Mediated by miRNA-138 in Bladder Cancer
por: El Ahanidi, Hajar, et al.
Publicado: (2022)

Recent advances in immune checkpoint inhibitors for non-small lung cancer treatment
por: Altaf, Reem, et al.
Publicado: (2022)

Living Weapons: Biological Weapons and International Security
por: Cieslak, Theodore J.
Publicado: (2010)

Aberrantly hypermethylated ARID1B is a novel biomarker and potential therapeutic target of colon adenocarcinoma
por: Baldi, Salem, et al.
Publicado: (2022)

Age-Based Disparities in Metastatic Melanoma Patients Treated in the Immune Checkpoint Inhibitors (ICI) Versus Non-ICI Era: A Population-Based Study
por: Safi, Mohammed, et al.
Publicado: (2021)

Suicide weapon
por: Barker, A. J.
Publicado: (1971)

Weapons & armor
Publicado: (1978)

Weapons and hope
por: Dyson, Freeman John
Publicado: (1984)

The Missile and the Weapon
por: Hall, A. L.
Publicado: (1900)

Death’s Weapons
Publicado: (1861)

Death’s Weapons
Publicado: (1882)

Death’s Weapons
Publicado: (1880)

Death’s Weapons
Publicado: (1877)

The Weapons of Death
Publicado: (1873)

Antiviral monoclonal antibody cocktails as a modern weapon in combating pandemics
por: Liu, Dingjiang, et al.
Publicado: (2021)

Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines
por: Al-Danakh, Abdullah, et al.
Publicado: (2022)

scGENA: A Single-Cell Gene Coexpression Network Analysis Framework for Clustering Cell Types and Revealing Biological Mechanisms
por: Algabri, Yousif A., et al.
Publicado: (2022)

Can Aspirin Use Be Associated With the Risk or Prognosis of Bladder Cancer? A Case-Control Study and Meta-analytic Assessment
por: Fan, Bo, et al.
Publicado: (2021)

PD-1/PDL-1 Inhibitors and Cardiotoxicity; Molecular, Etiological and Management Outlines
por: Safi, Mohammed, et al.
Publicado: (2020)

Role of Interleukin-34 in Cancer
por: Franzè, Eleonora, et al.
Publicado: (2020)

Checkpoint inhibition in hematologic malignancies
por: Tsumura, Aaron, et al.
Publicado: (2023)

Checkpoint Inhibitors and Engineered Cells: New Weapons for Natural Killer Cell Arsenal Against Hematological Malignancies
por: Giuliani, Massimo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_li31vc14cfscodav5df4mbi1c3